Sanderling Venture Partners VI LP, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), bought 61,256 shares at $7.00 ($325K) on 2011-02-08, disclosed to the SEC on 2011-02-10.
Open-market purchase of $325k PCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,877 | $0 | 0.0% |
| 2 | $7.00 | 46,379 | $325K | 100.0% |
| Total | $5.30 avg | 61,256 | $325K | 100% |
| Filing → |
| PCRX | SELL | 2013-03-11 | $10.4M | — | Filing → |